Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAME: Anti-VEGF Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser in Severe Diabetic Macular Oedema
NCT06985706Phase 3Recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- May 2025
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 3 trial of anti-VEGF intravitreal injection in diabetic macular edema (DME), sponsored by Belfast Health and Social Care Trust. Started May 2025; status: recruiting.
02
Drugs
anti-VEGF intravitreal injection
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT06985706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985706.